ConspectusTherapeutic nucleic acids have shown enormous potential to treat a vast number of diseases, ranging from cancers to inflammatory diseases. siRNA formulated within lipid nanoparticles (LNPs) ...

DALLAS, June 05, 2025--Signify Bio, a pioneering biotechnology company harnessing the human body for the production of in situ protein therapeutics, today announced an oversubscribed $15 million ...

Building on their previous work on polyurethane-based data storage, the researchers created a series of four monomers, each bearing a ferrocene group with a distinct electrochemical signature.

Bone diseases, such as bone metastases, pose significant therapeutic challenges due to the distinct physiological environment of skeletal tissues, which complicates the targeted delivery of nucleic ...

Google has open-sourced an AI model, SpeciesNet, designed to identify animal species by analyzing photos from camera traps.

The ideality factor was >1, which is expected from organic polymer semiconductors. The obtained spectroscopic/PEC results were explained by suggesting that PTF creates a better environment for forming ...

In vitro, ubiquitylation of nucleic acids on the 3′ adenosine nucleotide protects them from degradation by 3′ → 5′ nucleases. Lastly, we show—also in vitro—the reversibility of the DTX3L-mediated ...

Eli Lilly has opened a $700 m | Eli Lilly has opened a $700 million R&D center in the Boston Seaport, boosting its RNA and DNA research capabilities and expanding its biotech-hosting Gateway Labs ...

Researchers trace the 60-year evolution of lipid nanoparticles (LNPs) for nucleic acid delivery, highlighting their potential to revolutionize gene therapy with safer and more effective treatments.

Small nucleic acid drugs’ relatively strong drug-forming characteristics mean they could find a market domestically even without selling overseas. Xu Yao shares a similar view. Different regulatory ...